Welcome to our dedicated page for National Health Investors news (Ticker: NHI), a resource for investors and traders seeking the latest updates and insights on National Health Investors stock.
National Health Investors, Inc. (NHI) reports developments as a self-managed real estate investment trust focused on senior housing communities and medical facilities. The company owns, leases, operates and finances real estate through its Real Estate Investments and Senior Housing Operating Portfolio, or SHOP, segments, including independent living, assisted living, memory care, entrance-fee communities, senior living campuses, skilled nursing facilities and hospitals.
Recurring NHI news includes dividend declarations, earnings releases, investor updates, property investments, financing activity and governance changes. Company updates also cover sale-leaseback, joint venture, mortgage and mezzanine financing activity tied to senior housing and healthcare real estate.
National Health Investors (NYSE:NHI) has announced the pricing of an upsized public offering of 2,400,000 shares of common stock at $71.25 per share. The offering, expected to close on August 16, 2024, includes a 30-day option for underwriters to purchase up to 360,000 additional shares. NHI has entered into forward sale agreements with major financial institutions, allowing for future settlement within approximately 12 months. The company plans to use the net proceeds for working capital, acquisitions, debt repayment, and mortgage investments. This offering is made through an effective shelf registration statement and is being managed by leading investment banks.
National Health Investors (NYSE:NHI) has announced a public offering of 2,000,000 shares of its common stock. The offering includes a 30-day option for underwriters to purchase up to an additional 300,000 shares. NHI will enter into forward sale agreements with major financial institutions acting as forward purchasers. The company won't receive immediate proceeds from the sale but expects to settle the agreements within 12 months for cash. NHI plans to use the net proceeds for working capital, acquisitions, debt repayment, and mortgage investments. The offering is made under an effective shelf registration statement and will be conducted through a prospectus supplement and related documents available from the joint book-running managers: BofA Securities, J.P. Morgan, Wells Fargo Securities, and BMO Capital Markets.
National Health Investors (NYSE:NHI) has declared its third quarter 2024 dividend of $0.90 per common share. The dividend will be paid on November 1, 2024 to stockholders of record as of September 27, 2024. This announcement demonstrates NHI's commitment to providing regular returns to its shareholders, maintaining its dividend policy despite ongoing economic uncertainties. The consistency in dividend payments may be seen as a positive sign of the company's financial stability and confidence in its future performance.
National Health Investors, Inc. (NYSE:NHI), a real estate investment trust specializing in senior housing and medical investments, has issued an investor update. The update is available on the company's website under the 'Presentations and Webcasts' section. NHI's portfolio includes various types of senior living facilities such as independent living, assisted living, memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
NHI, founded in 1991, focuses on sale-leasebacks, joint ventures, senior housing operating partnerships, and mortgage and mezzanine financing for need-driven and discretionary senior housing and medical investments. This update provides investors with the latest information about the company's operations and performance.
National Health Investors (NYSE:NHI) announced its Q2 2024 results, showing improved performance compared to the previous year. Key highlights include:
- Net income per diluted share: $0.81 (Q2 2024) vs $0.92 (Q2 2023)
- NAREIT FFO per diluted share: $1.18 (Q2 2024) vs $1.05 (Q2 2023)
- Normalized FFO per diluted share: $1.18 (Q2 2024) vs $1.06 (Q2 2023)
- Normalized FAD: $51.8 million (Q2 2024) vs $44.6 million (Q2 2023)
NHI updated its 2024 guidance, raising NAREIT FFO, Normalized FFO, and Normalized FAD ranges. The company reported increased rental income, higher SHOP NOI, and new investments totaling $56.6 million with an 8.4% average initial yield. NHI also has $155.4 million in signed LOIs with an 8.4% average yield and is evaluating $270 million in potential investments.
National Health Investors (NYSE:NHI) has announced the schedule for its second quarter 2024 earnings release and conference call. The company will release its Q2 2024 results after market close on Tuesday, August 6, 2024. A conference call to discuss the results is scheduled for Wednesday, August 7, 2024, at 11:00 a.m. Eastern Time.
Investors and analysts can participate in the interactive teleconference by calling (888) 506-0062 with the confirmation number 781474. Additionally, a live broadcast of the conference call will be available online at www.nhireit.com and https://www.webcaster4.com/Webcast/Page/633/50711. An online replay of the call will be accessible shortly after the live broadcast and will remain available for one year.
National Health Investors, Inc. (NHI) filed a supplemental proxy statement with the SEC detailing steps taken by the Board of Directors in response to stockholders' concerns. The Board plans to propose amending the Articles of Incorporation, search for a new director, and evaluate Board composition.
National Health Investors, Inc. (NYSE:NHI) will pay a second quarter dividend of $0.90 per common share on August 2, 2024, to stockholders of record as of June 28, 2024.
National Health Investors, Inc. (NYSE:NHI) has issued an investor update focusing on their real estate investments in senior housing and medical facilities. NHI's diverse portfolio includes various types of healthcare properties. For more details, visit their website.
National Health Investors, Inc. (NYSE:NHI) announced its Q1 2024 results, showing net income per share of $0.71, NAREIT FFO per share of $1.10, and Normalized FFO per share of $1.12. The company updated its 2024 annual guidance and reported various financial figures. NHI's CEO highlighted deferral repayments, revenue growth, and raised guidance for the full year, emphasizing internal growth potential and financial strength.